Fundz

Plasmagen Biosciences Appoints Vivek V Kamath as Chief Executive Officer

Oct 07, 2025

Position

Chief Executive Officer

Company

PlasmaGen Biosciences

Vivek V Kamath
ManufacturingBiotechnologyPharmaceutical Manufacturingpharmaceuticals

Description

Plasmagen Biosciences announced the appointment of Vivek V Kamath as its Chief Executive Officer, effective October 6, 2025. Kamath brings over three decades of leadership experience in healthcare and has held senior roles in prominent organizations. His expertise is expected to drive Plasmagen’s mission of becoming a leading biopharmaceutical company.

Quick answer

Plasmagen Biosciences Appoints Vivek V Kamath as Chief Executive Officer (October 7, 2025).

Who is the new Chief Executive Officer at PlasmaGen Biosciences?
PlasmaGen Biosciences named Vivek V Kamath Chief Executive Officer, announced October 7, 2025.
What did PlasmaGen Biosciences announce on October 7, 2025?
Plasmagen Biosciences announced the appointment of Vivek V Kamath as its Chief Executive Officer, effective October 6, 2025. Kamath brings over three decades of leadership experience in healthcare and has held senior roles in prominent organizations.
What does PlasmaGen Biosciences do?
PlasmaGen BioSciences Private Limited is India’s first company dedicated to Plasma Protein Therapeutics, founded in 2010 and headquartered in Bengaluru.
Which similar companies made leadership changes around the same time?
FAMAR Group (September 29, 2025), Veranova (September 29, 2025), Medison (October 23, 2025) and Dr. Reddy's Laboratories (October 24, 2025) also announced leadership changes within 45 days of PlasmaGen Biosciences.

Source: Fundz verified event record.

Other recent leadership changes in Pharmaceutical Manufacturing and pharmaceuticals

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at PlasmaGen Biosciences, and when

A new leader at PlasmaGen Biosciences brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day PlasmaGen Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at PlasmaGen Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at PlasmaGen Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

PlasmaGen Biosciences

Location

160 5th Main Road

About

PlasmaGen BioSciences Private Limited is India’s first company dedicated to Plasma Protein Therapeutics, founded in 2010 and headquartered in Bengaluru. Established to address the critical gap between the demand and supply of plasma protein products, PlasmaGen is committed to improving patient health and quality of life across India. The company also drives nationwide awareness on plasma utilization and rare diseases such as Hemophilia, Thalassemia, and Primary Immunodeficiencies. With its upcoming manufacturing facility in Kolar, PlasmaGen is advancing India’s goal of self-sufficiency in plasma-derived medicinal products while promoting innovation, awareness, and national health resilience.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment PlasmaGen Biosciences changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Vinod
Likely contact at this company
••••••••@••••••••

See Vinod's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for PlasmaGen Biosciences's next move

Learn about Strategic plan

PlasmaGen Biosciences changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.